標(biāo)題: Titlebook: Management of Macular Hemorrhage; Lars-Olof Hattenbach Book 2018 Springer International Publishing AG, part of Springer Nature 2018 Anti-V [打印本頁] 作者: cucumber 時(shí)間: 2025-3-21 16:16
書目名稱Management of Macular Hemorrhage影響因子(影響力)
書目名稱Management of Macular Hemorrhage影響因子(影響力)學(xué)科排名
書目名稱Management of Macular Hemorrhage網(wǎng)絡(luò)公開度
書目名稱Management of Macular Hemorrhage網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Management of Macular Hemorrhage被引頻次
書目名稱Management of Macular Hemorrhage被引頻次學(xué)科排名
書目名稱Management of Macular Hemorrhage年度引用
書目名稱Management of Macular Hemorrhage年度引用學(xué)科排名
書目名稱Management of Macular Hemorrhage讀者反饋
書目名稱Management of Macular Hemorrhage讀者反饋學(xué)科排名
作者: 路標(biāo) 時(shí)間: 2025-3-21 20:19 作者: Guaff豪情痛飲 時(shí)間: 2025-3-22 02:03 作者: 含糊其辭 時(shí)間: 2025-3-22 05:33 作者: 裝飾 時(shí)間: 2025-3-22 11:40
Macular Haemorrhages: Natural Course and Risk Factors,Subretinal haemorrhage is a rare but serious complication that occurs in conjunction with macular diseases. The most common cause is choroidal neovascularisation (CNV) in the eyes with age-related macular degeneration (AMD). In some series, more than 80% of patients with submacular haemorrhage had underlying AMD [1, 2].作者: jaunty 時(shí)間: 2025-3-22 15:03
Macular Translocation,Since its introduction intravitreal anti-VEGF therapy (ranibizumab, bevacizumab) for neovascular age-related macular degeneration has improved the therapeutical options and outcomes for patients with neovascular age-related macular degeneration [1–4].作者: 詞匯 時(shí)間: 2025-3-22 20:50
The Pathophysiology of Subretinal Hemorrhage,oroidal or retinal circulation or both. Different pathological entities affecting these circulatory systems as well as trauma may be the cause of SRH. Independently from the underlying trigger, SRH damages tissue through a variety of mechanisms: The presence of iron, hemosiderin, and fibrin in the b作者: Genteel 時(shí)間: 2025-3-22 23:50
Classification of Macular Hemorrhages,the underlying pathology, commonly a choroidal neovascular membrane (CNVM), especially in AMD patients, followed by non-AMD-related CNVM and retinal arterial macroaneurysms (RAM) and (2) the extent and location of the hemorrhage including size, thickness, and location in relation to the fovea and th作者: 使隔離 時(shí)間: 2025-3-23 04:22
Subretinal Co-application of rtPA and Bevacizumab for Neovascular AMD with Submacular Hemorrhage,a macular scar with poor visual function is the usual outcome. While several surgical treatment approaches have been proposed to date, there is no general consensus regarding optimal treatment of acute SMH. Vitrectomy with subretinal co-application of recombinant tissue plasminogen activator (rtPA) 作者: JIBE 時(shí)間: 2025-3-23 07:52 作者: PAEAN 時(shí)間: 2025-3-23 13:09 作者: Metastasis 時(shí)間: 2025-3-23 15:37 作者: explicit 時(shí)間: 2025-3-23 20:12 作者: 骯臟 時(shí)間: 2025-3-24 01:20 作者: 我要沮喪 時(shí)間: 2025-3-24 04:58 作者: 四海為家的人 時(shí)間: 2025-3-24 09:48 作者: 無可非議 時(shí)間: 2025-3-24 11:14
Jost Hillenkamp MDpast two decades, an important demographic and epidemiological transition has taken place. Age-related and long-term chronic illnesses have replaced communicable diseases as the biggest challenge that health systems must now address. More than half of the growing number of people aged over 65 in Eur作者: canonical 時(shí)間: 2025-3-24 15:38
Lars-Olof Hattenbach M.D., F.E.B.O.ry at the time of writing this chapter, and has contributed to the emergence of new generations of technologies in several fields of healthcare. Policy instruments have been introduced by the European Commission at European Union (EU) level to support innovation and faster deployment of eHealth movi作者: CYN 時(shí)間: 2025-3-24 22:58
Gerald Seidel M.D., P.D., Dr.Sc., F.E.B.O.,Anton Haas M.D., P.D.on and criminal activity. UTEC works in Lowell and Lawrence, MA, two cities with substantial immigrant populations experiencing income inequality and significant gang activity. UTEC helps proven-risk youth transition from gangs and/or incarceration to achieving sustainable employment and completing 作者: legacy 時(shí)間: 2025-3-25 01:02 作者: 郊外 時(shí)間: 2025-3-25 04:15
Gabor B. Scharioth M.D., Ph.D.r city leaders, urban community groups, residents, and other stakeholders is figuring out how to house, employ, transport, educate, and ensure access to opportunities for these growing populations. Innovations in city management, service provision, and use of technology are part of the solution. Eve作者: 裂隙 時(shí)間: 2025-3-25 09:08
Barbara Parolini M.D.,Attilio Di Salvatore M.D.,Alessandro Finzi M.D.rporate headquarters, several prominent foundations, a hospital network, and a vibrant nonprofit community. Nevertheless, at the opening of this case study, education outcomes were low, dropout rates were high, and health outcomes were poor. Despite the constant presence of community improvement ini作者: 原始 時(shí)間: 2025-3-25 11:58
etplace approach, connecting social purpose organizations with a community of professionals who can provide financial, technical, and coaching support. The idea behind the marketplace is that all participants give value to, and receive value from, each other..SIF’s marketplace consists of two accele作者: 弓箭 時(shí)間: 2025-3-25 18:36
Surgical and Nonsurgical Treatment of Pre-retinal Hemorrhages,ses and in the presence of additional pathologies that need to be surgically addressed, a vitrectomy should be considered. A vitrectomy is the most reliable way to remove the hemorrhage and allows for additional procedures such as intraoperative photocoagulation, membrane peeling, tamponades, and in作者: Isthmus 時(shí)間: 2025-3-25 20:27 作者: aristocracy 時(shí)間: 2025-3-26 02:27 作者: glomeruli 時(shí)間: 2025-3-26 08:08
Silvia Bopp MD,Alireza Mirshahi MD to face different challenges, many of which are considered in this chapter. Much of the basis for the text in this chapter is the work and experiences of the United Kingdom (UK) Council for Health Informatics Professions (UKCHIP, .) which is the regulatory body for health informaticians working in 作者: 其他 時(shí)間: 2025-3-26 11:41
Jost Hillenkamp MDenge as they have developed systemic and institutional structures that focus on cure rather than care. As a result, and particularly in an era of economic uncertainty, most countries and regions have begun the search for new and more integrated care models — supported by technological innovation — t作者: Deduct 時(shí)間: 2025-3-26 15:09
Lars-Olof Hattenbach M.D., F.E.B.O. deployment activities, have put many Member States in a leading position with respect to the deployment of eHealth and the harnessing of the corresponding benefits. This success in EU investment is analysed in this chapter through three different activities: various phases in research and developme作者: 檢查 時(shí)間: 2025-3-26 18:36
Gerald Seidel M.D., P.D., Dr.Sc., F.E.B.O.,Anton Haas M.D., P.D.es, cultural practices, and approaches designed to walk with the young people from disenfranchisement to education and to stable, long-term employment..This chapter explores UTEC’s overall approach, and then dives deeply into UTEC’s Mattress Recycling program, the first point of entry for its youth.作者: OATH 時(shí)間: 2025-3-26 21:33 作者: 慎重 時(shí)間: 2025-3-27 02:23
Gabor B. Scharioth M.D., Ph.D.es financial and strategic planning support to tackle their most pressing social issues. This chapter looks at how Living Cities pursues its work, particularly through TII, and the experiences of two cities engaged in the initiative—Baltimore, MD, and New Orleans, LA. Key lessons include a shared de作者: 收集 時(shí)間: 2025-3-27 06:38 作者: Postmenopause 時(shí)間: 2025-3-27 12:07 作者: MOTIF 時(shí)間: 2025-3-27 17:22 作者: 織布機(jī) 時(shí)間: 2025-3-27 19:42
Book 2018n extensive review of the literature supplement the important information on clinical decision making, surgical techniques, and typical pitfalls and invite the reader to explore the advantages and disadvantages of various approaches to the management of macular hemorrhage..作者: Peak-Bone-Mass 時(shí)間: 2025-3-27 23:57
sion making, surgical techniques, and typical pitfalls and invite the reader to explore the advantages and disadvantages of various approaches to the management of macular hemorrhage..978-3-030-09754-7978-3-319-65877-3作者: Epithelium 時(shí)間: 2025-3-28 02:10
what has been done before. The extreme finds its expression in the belief that e-business projects need not be managed at all. Some people view project management for e- business projects as an unnecessary bur978-3-540-42165-8978-3-642-56090-3作者: 食草 時(shí)間: 2025-3-28 09:04
Classification of Macular Hemorrhages,e layer in which the blood is present. We suggest a classification to be used for clinical decision-making and also in future studies when comparing efficacy of different treatment strategies for macular hemorrhage. This classification considers the size and extent, thickness, and the retinal layers involved.作者: colony 時(shí)間: 2025-3-28 11:07
Autologous Choroidal RPE Patch Transplantation in Hemorrhagic Age-Related Macular Degeneration,atches might be the future treatment for patients with maculopathies, RPE-choroidal patch transplantation can be considered, at the present time, as a good alternative in the treatment of wet AMD for patients who are not responding to anti-VEGF or PDT therapy.作者: fatty-streak 時(shí)間: 2025-3-28 15:53
ts, and prognostic criteria.Informative case presentations a.Sub- or preretinal hemorrhage involving the macula is a typical complication in a variety of ocular diseases, including age-related macular degeneration, arterial macroaneurysm, Valsalva retinopathy, and trauma. However, there is currently作者: SUE 時(shí)間: 2025-3-28 21:01 作者: 打谷工具 時(shí)間: 2025-3-29 00:06
Subretinal Co-application of rtPA and Bevacizumab for Neovascular AMD with Submacular Hemorrhage,vely. Experimental laboratory studies have shown that neither rtPA nor rtPA-generated plasmin cleaves or functionally inactivates bevacizumab. The experimental results show that both substances are compatible and may be co-applied in surgery.
